Australia's Nova Eye jumps most in over 2 mths on higher sales expectation

Nova Eye Medical

08/12/2023 24:57

** Shares of Nova Eye Medical Ltd  EYE.AX  rise as much as
13% to A$0.130, their biggest intraday gain since Oct. 5
    ** Medical tech co says all five of co's Medicare
Administrative Contractors (MACs) have deferred proposed USA
reimbursement changes of  glaucoma surgery  under local coverage
from Dec. 23 to Jan. 29
    ** Co says the deferral is positive as it will see sales of
its minimally invasive glaucoma surgery technology go up in near
term in the USA   
    ** Stock has fallen 58.9% this year as of last close

 (Reporting by Neha Soni)
 ((Neha.Soni@thomsonreuters.com;))